Statement of Cash Flows	4 Months Ended
	Dec. 31, 2020 USD ($)
Statement of Cash Flows [Abstract]
Net loss	$ (10,661,113)
Adjustments to reconcile net loss to net cash used in operating activities:
Transaction costs associated with the warrant liability	1,069,399
Fair value of warrant liability in excess of proceeds received in Private Placement	890,000
Change in fair value of warrant liability	8,629,500
Interest earned on marketable securities held in Trust Account	(5,916)
Unrealized gain on marketable securities held in Trust Account	(3,454)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(543,350)
Accrued expenses	71,510
Net cash used in operating activities	(553,424)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(345,000,000)
Net cash used in investing activities	(345,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	338,100,000
Proceeds from sale of Private Placement Warrants	8,900,000
Proceeds from promissory note—related party	177,225
Repayment of promissory note—related party	(177,225)
Payment of offering costs	(480,706)
Net cash provided by financing activities	346,544,294
Net Change in Cash	990,870
Cash—Beginning of period	0
Cash—End of period	990,870
Non-Cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	300,553,370
Change in value of Class A common stock subject to possible redemption	(8,550,800)
Deferred underwriting fee payable	$ 12,075,000